QuidelOrtho Statistics

Total Valuation

QuidelOrtho has a market cap or net worth of GBP 1.52 billion. The enterprise value is 3.42 billion.

Market Cap	1.52B
Enterprise Value	3.42B

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	67.26M
Shares Outstanding	n/a
Shares Change (YoY)	+0.71%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	62.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	11.63
PS Ratio	0.71
PB Ratio	0.66
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	13.18
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.51, with an EV/FCF ratio of -123.46.

EV / Earnings	-12.36
EV / Sales	1.67
EV / EBITDA	7.51
EV / EBIT	39.23
EV / FCF	-123.46

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.90.

Current Ratio	1.20
Quick Ratio	0.54
Debt / Equity	0.90
Debt / EBITDA	4.38
Debt / FCF	-75.15
Interest Coverage	0.63

Financial Efficiency

Return on equity (ROE) is -11.38% and return on invested capital (ROIC) is 1.27%.

Return on Equity (ROE)	-11.38%
Return on Assets (ROA)	1.12%
Return on Invested Capital (ROIC)	1.27%
Return on Capital Employed (ROCE)	2.18%
Revenue Per Employee	323,583
Profits Per Employee	-41,983
Employee Count	6,600
Asset Turnover	0.42
Inventory Turnover	2.56

Taxes

In the past 12 months, QuidelOrtho has paid 13.36 million in taxes.

Income Tax	13.36M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.01% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-38.01%
50-Day Moving Average	42.22
200-Day Moving Average	41.20
Relative Strength Index (RSI)	49.59
Average Volume (20 Days)	177

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.63

Income Statement

In the last 12 months, QuidelOrtho had revenue of GBP 2.14 billion and -277.08 million in losses. Loss per share was -4.12.

Revenue	2.14B
Gross Profit	1.00B
Operating Income	91.00M
Pretax Income	-263.72M
Net Income	-277.08M
EBITDA	433.12M
EBIT	91.00M
Loss Per Share	-4.12

Full Income Statement

Balance Sheet

The company has 98.88 million in cash and 2.08 billion in debt, giving a net cash position of -1.99 billion.

Cash & Cash Equivalents	98.88M
Total Debt	2.08B
Net Cash	-1.99B
Net Cash Per Share	n/a
Equity (Book Value)	2.32B
Book Value Per Share	34.30
Working Capital	162.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 115.33 million and capital expenditures -143.06 million, giving a free cash flow of -27.73 million.

Operating Cash Flow	115.33M
Capital Expenditures	-143.06M
Free Cash Flow	-27.73M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 46.94%, with operating and profit margins of 4.26% and -12.97%.

Gross Margin	46.94%
Operating Margin	4.26%
Pretax Margin	-12.35%
Profit Margin	-12.97%
EBITDA Margin	20.28%
EBIT Margin	4.26%
FCF Margin	n/a

Dividends & Yields

QuidelOrtho does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.71%
Shareholder Yield	n/a
Earnings Yield	-18.23%
FCF Yield	-1.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

QuidelOrtho has an Altman Z-Score of 1.03 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.03
Piotroski F-Score	5